334
Views
49
CrossRef citations to date
0
Altmetric
Original Research

Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy

, , , , , , & show all
Pages 6929-6939 | Published online: 30 Oct 2018

References

  • WanXMinYBludauHDrug combination synergy in worm-like polymeric micelles improves treatment outcome for small cell and non-small cell lung cancerACS Nano20181232426243929533606
  • YuanZQChenWLYouBGMultifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumorJ Control Release201726819821129061511
  • XiongYZhaoYMiaoLLinCMHuangLCo-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancerJ Control Release2016244637327840166
  • AuKMSatterleeAMinYFolate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: turning a bone antiresorptive agent into an anticancer therapeuticBiomaterials20168217819326763733
  • TartaroneARossiELeroseRPossible applications of circulating tumor cells in patients with non small cell lung cancerLung Cancer2017107596427339469
  • SunHCaoDWuHLiuHKeXCiTDevelopment of low molecular weight heparin based nanoparticles for metastatic breast cancer therapyInt J Biol Macromol201811234335529409771
  • WangZHeQZhaoWLuoJGaoWTumor-homing, pH- and ultrasound-responsive polypeptide-doxorubicin nanoconjugates overcome doxorubicin resistance in cancer therapyJ Control Release2017264667528837822
  • HegerZPolanskaHKrizkovaSCo-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancerColloids Surf B Biointerfaces201715013114027907860
  • XiaFHouWZhangCpH-responsive gold nanoclusters-based nanoprobes for lung cancer targeted near-infrared fluorescence imaging and chemo-photodynamic therapyActa Biomater20186830831929292171
  • MazumdarSItaliyaKSSharmaSChitkaraDMittalAEffective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticlesInt J Pharm20185431–29610629578081
  • SdJNamG-HKwakGYangYKwonICHarnessing designed nanoparticles: current strategies and future perspectives in cancer immunotherapyNano Today2017172337
  • WuttkeSLismontMEscuderoARungtaweevoranitBParakWJPositioning metal-organic framework nanoparticles within the context of drug delivery – a comparison with mesoporous silica nanoparticles and dendrimersBiomaterials201712317218328182958
  • FangYYangWChengLMengFZhangJZhongZEGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivoActa Biomater20176432333329030307
  • ZhouYQuanGWuQMesoporous silica nanoparticles for drug and gene deliveryActa Pharm Sin B20188216517729719777
  • XiaYYouPXuFLiuJXingFNovel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitroNanoscale Res Lett2015101349
  • XiaYLinZLiYTargeted delivery of siRNA using RGDfC-conjugated functionalized selenium nanoparticles for anticancer therapyJ Mater Chem B201753369416952
  • LiYLinZZhaoMMultifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cellsInt J Nanomedicine2016113065307627462151
  • LiYGuoMLinZPolyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosisInt J Nanomedicine2016116693670227994465
  • LiYLinZGuoMInhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virusInt J Nano-medicine20171257335743
  • XiaYWangCXuTTargeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapyRSC Adv20188419171926
  • XiaYXuTWangCNovel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapyInt J Nanomedicine20181314315929317822
  • XiaYGuoMXuTsiRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapyInt J Nanomedicine2018131539155229588583
  • LuesakulUPuthongSNeamatiNMuangsinNpH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cellsCarbohydr Polym201818184185029254044
  • LiWYiXLiuXZhangZFuYGongTHyaluronic acid ion-pairing nanoparticles for targeted tumor therapyJ Control Release201622517018226826304
  • ZhangLLiGGaoMRGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of EpirubicinColloids Surf B Biointerfaces2016144818927070055
  • WangYWangXDengFThe effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticlesJ Control Release201827913614629655991
  • FangZSunYXiaoHTargeted osteosarcoma chemotherapy using RGD peptide-installed doxorubicin-loaded biodegradable polymeric micelleBiomed Pharmacother20178516016827930982
  • LiYLinZGuoMInhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathwaysInt J Nanomedicine2018132005201629662313
  • XiaYChenQQinXSunDZhangJLiuJStudies of ruthenium(ii)-2,2′-bisimidazole complexes on binding to G-quadruplex DNA and inducing apoptosis in HeLa cellsNew J Chem2013371137063715
  • ZhangQHuangRTangQLeucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoterOnco Targets Ther2018112745275229785123
  • ZhangTLiuWMengWDownregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinomaOnco Targets Ther2018111929193929670368
  • BenferMKisselTCellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticlesEur J Pharm Biopharm201280224725622085653
  • XiaYZhaoMChenYFolate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapyRSC Adv20188462593225940
  • TranTTTranPHAminHHLeeBJBiodistribution and in vivo performance of fattigation-platform theranostic nanoparticlesMater Sci Eng C Mater Biol Appl20177967167828629067